文献速递皮肤肿瘤

美国基底细胞癌与皮肤鳞状细胞癌比例随年龄、性别、种族和地理区域的变化

Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
PubMed 文献 · JAMA Dermatol · 2020-01-01

IMPORTANCE: Defining which populations are affected by basal cell carcinoma (BCC) vs cutaneous squamous cell carcinoma (cSCC) may inform targeted public health strategies.…

要点

  • BCC与cSCC的治疗比例总体为1.69:1,所有人口学亚组中BCC均更常见。
  • 年轻患者BCC比例更高:18-39岁为9.63:1,40-64岁为2.92:1,≥65岁为1.33:1。
  • 女性BCC比例高于男性,但差异随年龄增长而缩小。

核心结论

  • 在无国家登记系统的情况下,理赔数据可增进对角质形成细胞癌流行病学的理解。
  • BCC在所有人口学亚组(包括黑人患者)中均比cSCC更常见。
  • 40岁以下人群中,女性BCC可能性是cSCC的12.6倍,男性为7.2倍,这些群体可能受益于针对BCC的公共卫生教育。

研究设计与样本

  • 横断面分析,使用Optum Clinformatics Data Mart去标识化数据,基于2012年1月1日至2016年12月31日的治疗理赔进行回顾性评估。
  • 采用多因素logistic回归评估人口学特征与治疗性角质形成细胞癌为BCC的比值比关联。

主要发现

  • 总体BCC比cSCC更可能被治疗,比值为1.69(95%CI 1.6899-1.6901)。
  • BCC与cSCC比值随年龄降低:18-39岁为9.63(95%CI 9.6088-9.6574),40-64岁为2.92(95%CI 2.9171-2.9187),≥65岁为1.33(95%CI 1.3289-1.3291),P<.001。
  • 女性BCC比例高于男性,但差异随年龄增长而缩小:18-39岁OR 1.67(95%CI 1.47-1.88),40-64岁OR 1.15(95%CI 1.12-1.19),≥65岁OR 0.98(95%CI 0.97-0.99),P<.001。
  • 所有种族中BCC均多于cSCC:亚洲1.60、黑人1.45、西班牙裔2.00、白人1.69。
  • BCC:cSCC比值存在地理差异,西部北中部分区最高(2.12),南大西洋分区最低(1.35)。

临床怎么用

  • 临床应认识到BCC在所有人口学群体中均比cSCC更常见,包括黑人患者。
  • 对年轻患者(尤其40岁以下女性)进行BCC相关公共卫生教育可能有益。
  • 理赔数据可作为角质形成细胞癌流行病学的补充监测工具。

局限性

  • 研究基于商业保险和Medicare Advantage理赔数据,可能不涵盖无保险或未就医人群。
  • 仅纳入确诊并治疗的患者,可能低估未治疗或未诊断的肿瘤。
  • 横断面设计无法推断因果或时间趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Defining which populations are affected by basal cell carcinoma (BCC) vs cutaneous squamous cell carcinoma (cSCC) may inform targeted public health strategies. Incidence of BCC and cSCC is not reported to national cancer registries, but claims data for the treatment of BCC and cSCC provide insights into the epidemiology of keratinocyte carcinoma. OBJECTIVE: To define differences in the ratio of BCC to cSCC in adults (age, ≥18 years) in a large database of patients with commercial insurance and Medicare Advantage coverage. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis used deidentified data derived from the Optum Clinformatics Data Mart to perform a retrospective evaluation of a large commercially insured cohort based on treatment claims from January 1, 2012, to December 31, 2016. Patients with a diagnosed and treated BCC or cSCC as determined by codes from the International Classification of Diseases, Ninth Revision, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, and Current Procedural Terminology were included. Data were analyzed from November 30, 2019, to March 20, 2020. EXPOSURE: Diagnosis and treatment of BCC or cSCC. MAIN OUTCOMES AND MEASURES: The ratio of BCC to cSCC based on age, sex, race, and geographic location. Multivariable logistic regression was used to assess how demographics were associated with the odds of a treated keratinocyte carcinoma being a BCC. RESULTS: Among the 985 317 claims for patients included in the analysis (61.59% for men; mean [SD] age, 69.82 [12.58] years), BCCs were 1.69 (95% CI, 1.6899-1.6901) times more likely than cSCCs to be treated in the United States from 2012 to 2016. Basal cell carcinomas were significantly more prevalent than cSCCs in younger patients (18-39 years, 9.63 [95% CI, 9.6088-9.6574] BCCs per cSCC; 40-64 years, 2.92 [95% CI, 2.9171-2.9187] BCCs per cSCC; and ≥65 years, 1.33 [95% CI, 1.3289-1.3291] BCCs per cSCC; P < .001). Basal cell carcinomas were significantly more prevalent than cSCCs in women vs men, except in adults 65 years or older (odds ratios [ORs], 0.98 [95% CI, 0.97-0.99] vs 1.67 [95% CI, 1.47-1.88] for those aged 18-39 and 1.15 [95% CI, 1.12-1.19] for those aged 40-64 years; P < .001). The difference in BCC:cSCC ratios between men and women diminished with increasing age (OR, 1.67 for 18-39 years, 1.15 for 40-64 years, and 0.98 for 65 years or older). Basal cell carcinoma was more prevalent than cSCC in all races, including Black patients (BCC:SCC ratios, 1.60 for Asian patients, 1.45 for Black patients, 2.00 for Hispanic patients, and 1.69 for White patients of all ages). The BCC:cSCC ratio varied based on geography, with the highest ratio in the West North Central census division (2.12) and the lowest ratio in the South Atlantic census division (1.35). CONCLUSIONS AND RELEVANCE: In the absence of a national registry, claims data can improve our understanding of the epidemiology of keratinocyte carcinomas. In this cross-sectional study, basal cell carcinomas were more common than cSCCs for all demographics, including in Black patients. In populations younger than 40 years, BCCs were 12.6 times more likely for women and 7.2 times more likely for men. These demographic groups may benefit from public health education focused on the presentation and management of BCCs.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Lukowiak TM, Aizman L, Perz A, et al. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States. JAMA Dermatol. 2020. PMID: 32845319. doi:10.1001/jamadermatol.2020.2571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。